Continuation rates of hormonal intrauterine devices in adolescents and young adults when placed for contraceptive and non-contraceptive indications.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 14 07 2023
revised: 03 10 2023
accepted: 05 10 2023
medline: 4 12 2023
pubmed: 9 10 2023
entrez: 8 10 2023
Statut: ppublish

Résumé

This study aimed to estimate and compare continuation rates of hormonal intrauterine devices (IUDs) when placed for contraceptive or menstrual management indications in adolescents and young adults. We conducted a secondary analysis of a prospectively collected database of all hormonal IUD insertions from January 1, 2017 through December 31, 2020, with at least 1-year follow-up, across four Adolescent Medicine practices. IUD insertions without known indication were excluded. A total of 936 IUD insertions were attempted, 45% for contraception only, 18% for menstrual management only, and 37% for both indications. Insertion was successful in 868 (93%) attempts, and success did not differ by indication (p = 0.74). The mean age at insertion was 18.9 years (SD = 2.4 years), with no difference by indication. Of the completed insertions, 650 (75%) had at least one follow-up during the data analysis period. Excluding those without follow-up, the overall continuation rates were 77% at 1 year, 66% at 2 years, and 54% at 3 years. While continuation rates did not differ by indication at 1 year, at 3 years, continuation was highest among those who sought the device for menstrual management only (contraception = 53%, menstrual = 57%, both = 53%, p < 0.01) Malposition was rare (4.0%), as was device expulsion (2.5%), and these did not differ by indication. IUD continuation rates were high among adolescents and young adults and did not significantly differ when placed for contraceptive or non-contraceptive indication in the first year of use. Adolescents and young adults may seek the hormonal IUD for contraception and/or menstrual management. Our study found that IUD continuation rates were high at 1 year regardless of the indication for utilization.

Identifiants

pubmed: 37806471
pii: S0010-7824(23)00410-9
doi: 10.1016/j.contraception.2023.110304
pii:
doi:

Substances chimiques

Contraceptive Agents, Female 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110304

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Jessica Y Shim (JY)

Division of Gynecology, Boston Children's Hospital, Boston, MA, USA. Electronic address: Jessica.shim@childrens.harvard.edu.

Morgan E Ryan (ME)

Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA.

Carly E Milliren (CE)

Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA.

Sofya Maslyanskaya (S)

Division of Adolescent Medicine, Children's Hospital at Montefiore, Bronx, NY, USA.

Claudia Borzutzky (C)

Division of Adolescent/Young Adult Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Sarah Golub (S)

Division of Adolescent Medicine, Seattle Children's Hospital, Seattle, WA, USA.

Sarah Pitts (S)

Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA, USA.

Amy D DiVasta (AD)

Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH